Posts

Showing posts with the label Fibromyalgia Treatment Market Size

High Prevalence of Cancer and R&D in Fibrosarcoma to Augment Growth of Fibrosarcoma Drugs Market

Image
A fibrosarcoma is an inflamed (malignant) tumor that originates from the connective fibrous tissue located at the ends of the bones of the lower arm or leg and then proceeds to spread to other surrounding tissues, causing extreme pain and complications. It's a form of cancer that typically grows slowly over an extended period of time. Fibrosarcoma may develop for several reasons, including: primary tumors at the facial prominences on one or both sides of the heart; fibrosarcoma may develop in response to an infection (such as those that occur in the stomach or esophagus); tumors may also develop on other areas of the body other than the skin. If you have any of these symptoms, you should contact your physician immediately. However, since the symptoms of fibrosarcoma are similar to those of other diseases, and because it's difficult to determine whether a disease exists, most people with fibrosarcoma are sent for check-ups each year. Market Dynamics High prevalence of cancer is ...

Increasing Prevalence And Incidence Of Chronic Disorder Is Escalating The Growth Of The Fibromyalgia Treatment Market

Image
  Fibromyalgia causes widespread fatigue, widespread pain, and various other kinds of discomforts. Symptoms closely resemble those of fibromyalgia, yet fibromyalgia usually affects only the soft tissue, never the joints. The exact cause is still unknown, but possible risk factors include trauma, rheumatoid disease, and various autoimmune diseases, including Lupus and multiple sclerosis. Fibromyalgia is also frequently associated with neurologic disorders and psychiatric diseases. Some of these conditions include depression, psychosis, post-traumatic stress disorder, delusional parasitosis, bulimia, anorexia nervosa, eating disorders, and drug abuse. The increasing prevalence of accidents around the globe is leading to chronic pain. This is creating demand for pain relieving drugs, thereby fueling the growth of the fibromyalgia treatment market . According to the National Center for Health Statistics, overall, the prevalence of chronic pain was 20.4%, and the prevalence of high-im...